Publications by authors named "A I Borzilov"

Endogenous antimicrobial peptides (AMPs) are evolutionarily ancient molecular factors of innate immunity that play a key role in host defense. The study of the diversity of animal defense peptides has important applications in the context of the growing global antimicrobial resistance. In this study using a transcriptome mining approach, we found three novel thanatin-like β-hairpin AMPs in the bean bug , named Rip-2, Rip-3, and Rip-4.

View Article and Find Full Text PDF

The antimicrobial resistance crisis along with challenges of antimicrobial discovery revealed the vital necessity to develop new antibiotics. Many of the animal proline-rich antimicrobial peptides (PrAMPs) inhibit the process of bacterial translation. Genome projects allowed to identify immune-related genes encoding animal host defense peptides.

View Article and Find Full Text PDF

Francisella tularensis, the causative agent of tularemia, is divided into three subspecies. Two of these, subspecies holarctica and tularensis, are highly pathogenic to humans and consequently relatively well studied. The third subspecies, mediasiatica, is rarely isolated and remains poorly studied.

View Article and Find Full Text PDF

Marine polychaetes represent an extremely rich and underexplored source of novel families of antimicrobial peptides (AMPs). The rapid development of next generation sequencing technologies and modern bioinformatics approaches allows us to apply them for characterization of AMP-derived genes and the identification of encoded immune-related peptides with the aid of genome and transcriptome mining. Here, we describe a universal bioinformatic approach based on the conserved BRICHOS domain as a search query for the identification of novel structurally unique AMP families in annelids.

View Article and Find Full Text PDF
Article Synopsis
  • Protegrin-1 (PG-1) is an antimicrobial peptide effective against drug-resistant ESKAPE pathogens, but its high toxicity to mammalian cells limits its use as a systemic antibiotic.
  • Researchers modified PG-1 by changing specific amino acids to create analogs that maintain strong antimicrobial properties while reducing hemolytic activity.
  • One promising analog, [V16R], showed a significant reduction in toxicity and a ≥30-fold improved therapeutic index, proving effective in a septicemia infection model and suggesting potential for future drug development.
View Article and Find Full Text PDF